methylprednisolone and Anemias, Iron-Deficiency

methylprednisolone has been researched along with Anemias, Iron-Deficiency in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boville, B; Hassan, N; Kovey, K; Ndika, A; Reischmann, D; Sterken, D	1
Ge, M; Huang, J; Huang, Z; Li, D; Li, X; Nie, N; Shao, Y; Shi, J; Zhang, J; Zheng, Y	1
Auerbach, M; Ballard, H; Chaudhry, M; Goldman, H	1
Davies, G; Gough, A; Johnson, AH; Lorenzi, AR	1

Reviews

1 review(s) available for methylprednisolone and Anemias, Iron-Deficiency

Article	Year
Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide. Annals of the rheumatic diseases, 2001, Volume: 60, Issue:8 Topics: Aged; Anemia, Iron-Deficiency; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gastric Antral Vascular Ectasia; Humans; Immunosuppressive Agents; Methylprednisolone; Pulse Therapy, Drug; Scleroderma, Systemic; Sclerotherapy; Treatment Outcome	2001

Article

Year

Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.

Annals of the rheumatic diseases, 2001, Volume: 60, Issue:8

Topics: Aged; Anemia, Iron-Deficiency; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gastric Antral Vascular Ectasia; Humans; Immunosuppressive Agents; Methylprednisolone; Pulse Therapy, Drug; Scleroderma, Systemic; Sclerotherapy; Treatment Outcome

2001

Trials

1 trial(s) available for methylprednisolone and Anemias, Iron-Deficiency

Article	Year
Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial. The Journal of laboratory and clinical medicine, 1998, Volume: 131, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Arthralgia; Double-Blind Method; Eosinophilia-Myalgia Syndrome; Female; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Methylprednisolone; Middle Aged; Muscular Diseases; Prospective Studies; Sex Characteristics; Syndrome	1998

Article

Year

Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial.

The Journal of laboratory and clinical medicine, 1998, Volume: 131, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Arthralgia; Double-Blind Method; Eosinophilia-Myalgia Syndrome; Female; Hematinics; Humans; Infusions, Intravenous; Iron-Dextran Complex; Male; Methylprednisolone; Middle Aged; Muscular Diseases; Prospective Studies; Sex Characteristics; Syndrome

1998

Other Studies

2 other study(ies) available for methylprednisolone and Anemias, Iron-Deficiency

Article	Year
Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency Anemia. The Annals of pharmacotherapy, 2017, Volume: 51, Issue:7 Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Erythropoietin; Female; Ferrosoferric Oxide; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Methylprednisolone; Pruritus; Retrospective Studies; Young Adult	2017
A novel tri-allelic mutation of TMPRSS6 in iron-refractory iron deficiency anaemia with response to glucocorticoid. British journal of haematology, 2014, Volume: 166, Issue:2 Topics: Alleles; Anemia, Iron-Deficiency; Child; Female; Glucocorticoids; Humans; Male; Membrane Proteins; Methylprednisolone; Mutation; Pedigree; Serine Endopeptidases	2014